BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Duan J, Wu L. Research advances in NQO1-responsive prodrugs and nanocarriers for cancer treatment. Future Med Chem 2022. [PMID: 35102756 DOI: 10.4155/fmc-2021-0289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Alwaili MA. Protective effects of lemongrass (Cymbopogon citratus STAPF) extract mediated mitochondrial fission and glucose uptake inhibition in SW1417. Food Sci Technol 2023;43. [DOI: 10.1590/fst.94522] [Reference Citation Analysis]
2 Zhang X, Ding J, Feng L, Wu H, Xu Z, Tao W, Wang Y, Zheng Y, Ling Y, Zhu P. Development of novel nitric oxide-releasing quinolinedione/furoxan hybrids as NQO1 inhibitors for intervention of drug-resistant hepatocellular cancer. Bioorganic Chemistry 2022;129:106174. [DOI: 10.1016/j.bioorg.2022.106174] [Reference Citation Analysis]
3 Fu R, Tsai C, Liu S, Chiu S, Chen Y, Chiang Y, Kuo Y, Shyu W, Lin S. Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway. Antioxidants 2022;11:2089. [DOI: 10.3390/antiox11112089] [Reference Citation Analysis]
4 Pavlova N, Miloshev GY, Georgieva AV, Traykovska M, Penchovsky R. Versatile tools of synthetic biology applied to drug discovery and production. Future Med Chem 2022. [PMID: 35975897 DOI: 10.4155/fmc-2022-0063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhu H, Lu L, Zhu W, Tan Y, Duan Y, Liu J, Ye W, Zhu Z, Xu J, Xu S. Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties. Eur J Med Chem 2022;240:114575. [PMID: 35803175 DOI: 10.1016/j.ejmech.2022.114575] [Reference Citation Analysis]